Alpha Crest Capital Management LLC Heron Therapeutics, Inc. Transaction History

Alpha Crest Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$4.63 - $9.94 $123,875 - $265,944	-26,755 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$8.35 - $12.6 $223,404 - $337,113	26,755 New	26,755 $244,000
Q2 2021 Aug 12, 2021	SELL	$13.27 - $18.48 $253,762 - $353,393	-19,123 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$14.49 - $20.72 $128,758 - $184,117	8,886 Added 86.8%	19,123 $310,000
Q4 2020 Feb 12, 2021	BUY	$14.61 - $22.14 $149,562 - $226,647	10,237 New	10,237 $217,000
Q3 2020 Nov 12, 2020	SELL	$13.67 - $17.77 $170,792 - $222,018	-12,494 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$10.89 - $21.47 $222,014 - $437,708	-20,387 Reduced 62.0%	12,494 $184,000
Q1 2020 May 13, 2020	BUY	$10.23 - $24.56 $193,439 - $464,405	18,909 Added 135.33%	32,881 $386,000
Q4 2019 Feb 12, 2020	BUY	$17.42 - $26.61 $243,392 - $371,794	13,972 New	13,972 $328,000

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $133M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.